Across the recent three months, 4 analysts have shared their insights on Zoetis (NYSE:ZTS), expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick ...

IonQ (NYSE:IONQ) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...

10 analysts have expressed a variety of opinions on Crocs (NASDAQ:CROX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ...

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Celldex Therapeutics CLDX in the last three months. The following table summarizes their recent ...